MRSO

MRSO EBITDA per Share

The EBITDA per Share of MRSO (5619.T) as of Nov 3, 2026 is -9.59 JPY. In the previous year, EBITDA per Share was 45.65 JPY — a change of -121.00% (lower).

EBITDA per Share

-9.59JPY

YoY

-121.00%

Last updated:

EBITDA per Share of MRSO is 2025 -9.59 JPY. EBITDA per Share of MRSO was 2024 45.65 JPY. It decreases by -121.00% lower compared to the previous year.

The MRSO EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
252.86 JPY
Jan 1, 2022
284.91 JPY
Jan 1, 2023
170.75 JPY
Jan 1, 2024
45.65 JPY
Jan 1, 2025
-9.59 JPY
The MRSO EBITDA per Share history
YEAREBITDA per ShareYoY
-9.59JPY-121.00%
45.65JPY-73.26%
170.75JPY-40.07%
284.91JPY+12.68%
252.86JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MRSO Stock analysis

What does MRSO do? MRSO Inc generates revenue through comprehensive healthcare platform services including HCPF, which operates MRSO.jp for medical checkup reservations. The company offers DX services for medical facilities featuring MRSO-Plus, a cloud-based reservation management system, and DX services for government with solutions like MRSO Jumin Kenshin, MRSO Vaccine, MRSO Form, and MRSO Go Yoyaku. Large-scale vaccination services provide an online reservation system for vaccinations. Medical facilities and government entities are the primary buyers of these services, utilizing MRSO-Plus for operational efficiency and government systems for public health initiatives. MRSO.jp serves as the core platform for medical checkup reservations, while MRSO Vaccine and MRSO Go Yoyaku target specific vaccination needs. The company’s DX services for medical facilities focus on improving marketing activities and operational efficiency through cloud-based solutions. Government clients purchase systems such as MRSO Jumin Kenshin for resident health checkups and MRSO Form for administrative processes, enhancing public health management. Revenue streams are derived from subscription models for MRSO-Plus, MRSO Vaccine, and other platform services. Medical facilities pay for MRSO-Plus to manage reservations and improve patient engagement, while government agencies invest in MRSO Jumin Kenshin and MRSO Form for large-scale health programs. The vaccination reservation system is a key product for both public health campaigns and routine medical services. MRSO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MRSO stock

EBITDA per Share of MRSO is -9.59 JPY in 2025.

EBITDA per Share of MRSO changed from 45.65 JPY to -9.59 JPY, representing a -121.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share MRSO since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MRSO

All Key Metrics — MRSO